DV
Dividend Vision

ARVN — Arvinas Inc

Arvinas Inc (ARVN)

Total return is -44.1% over the past 7.9 years, 244.4 points behind SPY at 200.3%. Its deepest 1-year drawdown was 49.5%.

ARVN is an equity stock fund focused on Arvinas Inc, a biotechnology company specializing in protein degradation technology and targeted protein degradation therapeutics. The fund does not currently pay distributions, making it unsuitable for income-focused investors seeking regular dividend payments. This holding is oriented toward investors interested in exposure to the biotechnology and life sciences sector with a growth-focused investment approach rather than current income generation.

ARVN key facts

Asset type
Stock
Asset class
Equity
Inception date
09/27/2018
Last close
$8.97
Market cap
$516,814,816
Average volume
461100.0
Beta
1.749
Payout ratio
0.0
P/E ratio
34.6538
Forward P/E
17.8571
EPS
$-3.18